remdesivir | Page 5 | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
May 09, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, MAY 09, 2025

remdesivir

Vials of investigational coronavirus disease (Covid-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US March 18, 2020. Gilead Sciences Inc/Handout via Reuters
Health

Govt hospitals to get Beximco Remdesivir for free 

Since the government is treating Covid-19 patients for free, Beximco Pharma will not take any money for Remdesivir supply to public hospitals    

A vial of Remdesivir. Photographer: Ulrich Perrey/Getty Images
Coronavirus chronicle

First copies of Gilead virus drug to start selling in Bangladesh

Photo: Collected
Covid-19 in Bangladesh

It’ll take 2-3 days to get Remdesivir: Health minister

A man in a protective suit prepares to meet people who took part in a Muslim congregation hit by the coronavirus, on March 31, 2020 in New Delhi, India. Photo: Hindustan Times
Coronavirus chronicle

Health groups ask India to rescind Gilead's patents for Covid-19 drug remdesivir

File Photo: Vials of investigational coronavirus disease (Covid-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US March 18, 2020. Picture taken March 18, 2020. Gilead Sciences Inc/Handout via Reuters
Health

Remdesivir free for all though it costs Tk60k a patient

File Photo: Vials of investigational coronavirus disease (Covid-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US March 18, 2020. Picture taken March 18, 2020. Gilead Sciences Inc/Handout via Reuters
Pharma

Beximco claims to be the first to produce Remdesivir, not Eskayef

Photo: Collected
Health

Eskayef produces Remdesivir in Bangladesh

File Photo: Vials of investigational coronavirus disease (Covid-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US March 18, 2020. Picture taken March 18, 2020. Gilead Sciences Inc/Handout via Reuters
Health

Bangladesh likely to start using Remdesivir by May 20, vaccine trial starts in June

FILE PHOTO: A lab technician visually inspects a filled vial of investigational coronavirus disease (COVID-19) treatment drug remdesivir at a Gilead Sciences facility in La Verne, California, U.S. March 11, 2020. Picture taken March 11, 2020. Gilead Sciences Inc/Handout via REUTERS.
Coronavirus chronicle

Japan approves Gilead Sciences' remdesivir as Covid-19 drug

Photo: Collected
Coronavirus chronicle

Coronavirus drug remdesivir will be available this week: Gilead CEO

Photo: Collected
Coronavirus chronicle

Gilead Sciences exporting remdesivir, CEO says

File Photo: Vials of investigational coronavirus disease (Covid-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US March 18, 2020. Picture taken March 18, 2020. Gilead Sciences Inc/Handout via Reuters
Health

Govt permits 6 companies to produce Covid-19 drug remdesivir

File Photo: Vials of investigational coronavirus disease (Covid-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US March 18, 2020. Picture taken March 18, 2020. Gilead Sciences Inc/Handout via Reuters
Coronavirus chronicle

US FDA authorizes emergency use of Covid-19 drug remdesivir

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net